| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/14/2013 | US8440661 Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines |
| 05/14/2013 | CA2557433C Quinazoline derivatives and therapeutic use thereof |
| 05/14/2013 | CA2535714C Phenoxyacetic acid derivatives |
| 05/10/2013 | WO2013065725A1 Phthalamide derivative, pesticide for agricultural and horticultural applications which comprises said derivative, and method of utilizing said pesticide |
| 05/10/2013 | WO2013064883A1 Heteroaryl compounds as sodium channel blockers |
| 05/10/2013 | WO2013064681A1 N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use |
| 05/10/2013 | WO2013064543A1 Pharmaceutical compounds |
| 05/10/2013 | WO2013064520A1 Pesticidal compounds |
| 05/10/2013 | WO2013064518A1 Pesticidal compounds |
| 05/10/2013 | WO2013064128A1 Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof |
| 05/10/2013 | WO2013064083A1 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof |
| 05/10/2013 | CA2854083A1 Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof |
| 05/10/2013 | CA2853723A1 N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use |
| 05/10/2013 | CA2853581A1 Pesticidal compounds |
| 05/10/2013 | CA2853008A1 Pharmaceutical compounds |
| 05/09/2013 | US20130116433 Process for the production of etravirine |
| 05/09/2013 | US20130116269 Cyclic n,n'-diarylthioureas and n,n'-diarylureas - androgen receptor antagonists, anticancer agent, method for preparation and use thereof |
| 05/09/2013 | US20130116266 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 05/08/2013 | EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 05/08/2013 | EP2589597A2 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (PBR) |
| 05/08/2013 | EP2589596A1 Aromatic amine derivative, and organic electroluminescent element comprising same |
| 05/08/2013 | EP2588474A2 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
| 05/08/2013 | EP2588450A1 Napht- 2 -ylacetic acid derivatives to treat aids |
| 05/08/2013 | CN103097361A 1-(aryl methyl)-quinazoline-2,4-dione as parp inhibitor and its application |
| 05/08/2013 | CN103097360A Process for preparing antiviral compounds |
| 05/08/2013 | CN103087043A Benzamide derivative resisting proliferative activity and pharmaceutical preparation thereof |
| 05/08/2013 | CN103086984A 4-phenylamino quinazoline derivative, preparation method and application thereof |
| 05/08/2013 | CN103086983A Preparation method for 4,6-dimethoxy pyrimidineurea |
| 05/08/2013 | CN103086982A Pyrimidine derivative salts |
| 05/08/2013 | CN103086981A New compounds |
| 05/08/2013 | CN103086980A Pyrimidine compound for efficiently promoting stem cell proliferation and use thereof |
| 05/08/2013 | CN103086881A Method for synthesizing alpha-hydroxy carboxylic ester with 2-hydroxy propylene cyanide |
| 05/08/2013 | CN103086818A Method for synthesizing alpha-oxyamide with 2-hydroxy propylene cyanide |
| 05/08/2013 | CN102229571B 5-fluorouracil drug intermediate, preparation method and application thereof |
| 05/08/2013 | CN101827817B Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 05/08/2013 | CN101821243B Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 05/08/2013 | CN101768036B Method for preparing heterocyclic aromatic compound replaced by aryl in alcohol solvent |
| 05/08/2013 | CN101631778B Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors |
| 05/08/2013 | CN101460483B Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor |
| 05/08/2013 | CN101355946B Compounds for modulating TRPV3 function |
| 05/07/2013 | US8436167 Chemical compounds |
| 05/07/2013 | US8436029 Pharmaceutical forms, and methods of making and using the same |
| 05/07/2013 | US8436009 Prodrug of triazolone compound |
| 05/07/2013 | US8436007 Inhibitors of protein kinases |
| 05/07/2013 | US8436006 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| 05/07/2013 | US8435990 Dihydropyrimidone amides as P2X7 modulators |
| 05/07/2013 | US8435968 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use |
| 05/07/2013 | CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/07/2013 | CA2574827C 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2013 | CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 05/07/2013 | CA2507334C Pyrimidine-sulfamides and their use as endothelian receptor antagonist |
| 05/02/2013 | WO2013060837A1 Synthesis of triazolopyrimidine compounds |
| 05/02/2013 | WO2013060098A1 Kinase inhibitor and method for treatment of related diseases |
| 05/02/2013 | WO2013060023A1 Preparation method and intermediate of quinazoline derivative |
| 05/02/2013 | US20130109713 Antimicrobial agents |
| 05/02/2013 | US20130109708 Chemical Compounds |
| 05/02/2013 | US20130109707 Fluorouracil derivatives |
| 05/02/2013 | US20130109706 Quinazoline-based t cell proliferation inhibitors |
| 05/02/2013 | US20130109702 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 05/02/2013 | US20130109698 Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein |
| 05/02/2013 | US20130109669 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
| 05/02/2013 | US20130109573 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides |
| 05/02/2013 | US20130108610 Inhibition of Microbial Growth by Aconitase Inhibition |
| 05/02/2013 | CA2853440A1 Kinase inhibitor and method for treatment of related diseases |
| 05/02/2013 | CA2853097A1 Novel trpv3 modulators |
| 05/02/2013 | CA2852652A1 Synthesis of triazolopyrimidine compounds |
| 05/01/2013 | EP2586773A1 Synthesis of Triazolopyrimidine Compounds |
| 05/01/2013 | EP2585439A1 Heterocyclic compounds, their preparation and their therapeutic application |
| 05/01/2013 | EP2585437A2 Thioacetate compounds, compositions and methods of use |
| 05/01/2013 | CN103081155A Light-emitting element |
| 05/01/2013 | CN103073588A Functional ionic liquid and its application |
| 05/01/2013 | CN103073509A Preparation method of quinazoline derivative |
| 05/01/2013 | CN103073508A Kinase inhibitor and method for treating related diseases |
| 05/01/2013 | CN103073507A Sulfonylurea compound |
| 05/01/2013 | CN103073506A Synthetic method of 2-hydroxyl-4,6-dimethyl pyrimidine hydrochloride |
| 05/01/2013 | CN103073505A Method for synthesizing 4,6-dichloropyrimidine with 4-chlorine-6-methoxypyrimidine |
| 05/01/2013 | CN103073460A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 05/01/2013 | CN102267951B Method for purifying urapidil with counter solvent recrystallization method |
| 05/01/2013 | CN101784531B 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
| 05/01/2013 | CN101379022B Benzamide and heteroarene derivatives |
| 05/01/2013 | CN101341134B 嘧啶衍生物 Pyrimidine derivatives |
| 04/30/2013 | US8431710 Process for the synthesis of halogenated cyclic compounds |
| 04/30/2013 | US8431697 Triallyl isocyanurate, triallyl cyanurate and process for producing triallyl isocyanurate |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/30/2013 | US8431573 Cyanopyrimidinones |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/25/2013 | WO2013059572A1 Process for the preparation of etravirine and intermediates in the synthesis thereof |
| 04/25/2013 | WO2013059215A1 Substituted biaryl alkyl amides |
| 04/25/2013 | WO2013059194A1 Meldrum 's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors |
| 04/25/2013 | WO2013057711A1 Quinazoline derivatives as pi3k modulators |
| 04/25/2013 | WO2013057545A1 Acid addition salts of bosentan |
| 04/25/2013 | WO2013057468A1 Process for the preparation of an endothelin receptor antagonist |
| 04/25/2013 | WO2012166706A3 Supramolecular nanofibers and hydrogels based on oligopeptides functionalized with nucleobases |
| 04/25/2013 | US20130102782 Processes and intermediates for producing azaindoles |
| 04/25/2013 | US20130102779 Substituted Tetracycline Compounds |
| 04/25/2013 | US20130102774 Thionation process and a thionating agent |
| 04/25/2013 | US20130102623 Tricyclic Compounds Having Cytostatic and/or Cytotoxic Activity and Methods of Use Thereof |
| 04/25/2013 | US20130102622 Novel Quinazoline-2,4-Dione Derivative, and Medical Compositions for the Prophylaxis and Treatment of Cranial Nerve Disease Containing the Same |
| 04/25/2013 | US20130102617 Method of treating diabetes, metabolic syndrome and obesity using phenylacetamide derivative |